Indian drug makers wary as US FDA sharpens focus on quality controlPost published:May 16, 2017Post category:Industry NewsThe US FDA has increased the frequency of its inspections but also intensified scrutiny on drug manufacturing facilities in India Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostFacebook’s Sheryl Sandberg urges family-friendly policies on Mother’s Day Next PostLithium supply may be key to government’s electric vehicles push You Might Also Like Hexagon’s Manufacturing Intelligence division announces PC-DMIS 2019 R1 March 1, 2019 Gage Studies and Gage R&R December 18, 2017 Poor quality Chinese solar modules flood Indian market September 7, 2017